荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

未开盘 07-22 16:08:56

20.100

+0.340

+1.72%

最高20.400	最低19.220	成交量10.48万
今开19.220	昨收19.760	日振幅5.97%
总市值44.64亿	流通市值41.15亿	总股本2.22亿
成交额208.55万	换手率0.05%	流通股本2.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":20.1,"timestamp":1721635736031,"preClose":19.76,"halted":0,"volume":104800,"delay":0,"floatShares":204749200,"shares":222071600,"eps":-2.6409845,"marketStatus":"未开盘","marketStatusCode":0,"change":0.34,"latestTime":"07-22 16:08:56","open":19.22,"high":20.4,"low":19.22,"amount":2085480,"amplitude":0.059717,"askPrice":20.1,"askSize":1000,"bidPrice":19.6,"bidSize":1200,"shortable":0,"etf":0,"ttmEps":-2.640984470250314,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1710864000000,"adjPreClose":19.76,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.9468738717301555,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509/tweets","defaultTab":"tweets","newsList":[{"id":"2453043842","title":"华东医药与荃信生物就IL-4Rα单抗达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2453043842","media":"医药魔方","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453043842?lang=zh_cn&edition=full","pubTime":"2024-07-22 07:40","pubTimestamp":1721605238,"startTime":"0","endTime":"0","summary":"7月21日，华东医药与荃信生物联合宣布，华东医药全资子公司中美华东与荃信生物再度联手，双方就荃信生物自主研发的QX005N注射液签署合作开发及市场推广服务协议。目前，QX005N注射液针对成人中重度特应性皮炎及结节性痒疹的两项III期临床试验均在入组中。此外，中美华东也将获得该产品上市许可持有人转让的优先合作权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072208005095e66630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072208005095e66630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2453227788","title":"港股公告掘金 | 兖矿能源筹划与高地资源的战略合作，或将成为高地资源的第一大股东并取得控制权","url":"https://stock-news.laohu8.com/highlight/detail?id=2453227788","media":"智通财经","labels":["Shareholding Changes","Company Corporation"],"top":-1,"share":"https://www.laohu8.com/m/news/2453227788?lang=zh_cn&edition=full","pubTime":"2024-07-21 19:25","pubTimestamp":1721561129,"startTime":"0","endTime":"0","summary":"【重大事项】：兖矿能源(01171)筹划与高地资源的战略合作，或将成为高地资源的第一大股东并取得控制权英皇国际(00163)拟11.547亿港元出售香港非核心投资物业荃信生物-B(02509)与中美华东就QX005N的开发及潜在商业化合作订立合作协议知乎-W(02390)拟要约回购4692.14万股A类普通股【财务业绩】：金地商置(00535)发盈警，预期中期股东应占亏损约20亿元至23亿元 同比","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes,Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1216","BK1178","BK1538","HSTECH","YANG","HSCEI","BK0196","BK0266","00163","BK0187","BK1095","BK0188","01171","00535","02390","BK1161","02509","BK0028","SGXZ49509284.SGD","600188","SGXZ81163826.USD","BK1594"],"gpt_icon":1},{"id":"2453221713","title":"荃信生物-B(02509)与中美华东就QX005N的开发及潜在商业化合作订立合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2453221713","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453221713?lang=zh_cn&edition=full","pubTime":"2024-07-21 18:26","pubTimestamp":1721557601,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 发布公告，于2024年7月19日，公司与华东医药的全资附属公司中美华东订立合作协议，公司向中美华东授予标的产品在授权地区和授权领域内的排他共同合作开发权;独家市场推广选择权;及上市许可持有人转让的优先权。根据合作协议，中美华东与公司共同开展临床及非临床研究及注册相关工作。合作协议使集团利用中美华东资源及既有能力在相关市场迅速建立优势地位，并提升集团的长期增长潜力及全面竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2452454429","title":"荃信生物-B(02509)斥资1.6亿元认购浦发银行提供的两项理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2452454429","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452454429?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:59","pubTimestamp":1721386798,"startTime":"0","endTime":"0","summary":"荃信生物-B(02509)发布公告，于2024年7月19日，为有效利用闲置资金，公...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_46.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_46.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0028","BK0183","02509","BK0187","BK0201","BK0278","BK1161","BK0015","LU1979443071.USD","BK0012","LU1934453819.USD","BK0086","BK0188","600000"],"gpt_icon":0},{"id":"2451667486","title":"荃信生物－Ｂ(02509)股价下跌7.176%，现价港币$20.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2451667486","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451667486?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:40","pubTimestamp":1721011200,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在上午10:40比前收市价下跌7.176%，现股价为港币$20.05。至目前为止，今日最高价为$20.05，而最低价为$20.05。总成交量为800股，总成交金额为港币$1.604万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240715751/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2450283993","title":"荃信生物－Ｂ(02509)股价下跌6.744%，现价港币$20.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2450283993","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450283993?lang=zh_cn&edition=full","pubTime":"2024-07-12 10:13","pubTimestamp":1720750380,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在上午10:13比前收市价下跌6.744%，现股价为港币$20.05。至目前为止，今日最高价为$20.05，而最低价为$20.05。总成交量为600股，总成交金额为港币$1.203万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407121495/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2450067224","title":"荃信生物－Ｂ(02509)股价显著下跌11.077%，现价港币$17.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2450067224","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450067224?lang=zh_cn&edition=full","pubTime":"2024-07-09 14:22","pubTimestamp":1720506120,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在下午02:22比前收市价显著下跌11.077%，现股价为港币$17.5。至目前为止，今日最高价为$19.5，而最低价为$17.5。总成交量为1000股，总成交金额为港币$1.9万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407091290/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2448602117","title":"荃信生物(02509.HK)共斥2.6亿人币认购理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2448602117","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448602117?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:20","pubTimestamp":1719969600,"startTime":"0","endTime":"0","summary":"荃信生物(02509.HK) 公布，于今年4月至6月，分别与浦发银行(600000.SH) 、江苏银行(600919.SH) 及工商银行(01398.HK) 签订认购协议，认购本金额合共为2.6亿元人民币的理财产品。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-07-02 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180119144847470_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180119144847470_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1360972/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2448898130","title":"荃信生物-B(02509)：认购理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2448898130","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448898130?lang=zh_cn&edition=full","pubTime":"2024-07-02 19:32","pubTimestamp":1719919927,"startTime":"0","endTime":"0","summary":"荃信生物-B(02509)发布公告，公司已分别与浦发银行、江苏银行及工商银行签订认...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_2.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_2.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2448900653","title":"荃信生物－Ｂ(02509)股价上升8.415%，现价港币$19.84","url":"https://stock-news.laohu8.com/highlight/detail?id=2448900653","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448900653?lang=zh_cn&edition=full","pubTime":"2024-07-02 14:10","pubTimestamp":1719900600,"startTime":"0","endTime":"0","summary":"[上升股]荃信生物－Ｂ(02509) 股价在下午02:10比前收市价上升8.415%，现股价为港币$19.84。至目前为止，今日最高价为$19.84，而最低价为$16.8。总成交量为7.8万股，总成交金额为港币$137.757万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407022699/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2446320344","title":"荃信生物－Ｂ(02509)股价下跌8.073%，现价港币$25.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2446320344","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446320344?lang=zh_cn&edition=full","pubTime":"2024-06-27 10:00","pubTimestamp":1719453600,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在上午10:00比前收市价下跌8.073%，现股价为港币$25.05。至目前为止，今日最高价为$27.2，而最低价为$25.05。总成交量为1.18万股，总成交金额为港币$30.926万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406271435/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2444170526","title":"荃信生物－Ｂ(02509)股价显著上升12.527%，现价港币$26.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2444170526","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444170526?lang=zh_cn&edition=full","pubTime":"2024-06-18 15:32","pubTimestamp":1718695920,"startTime":"0","endTime":"0","summary":"[上升股]荃信生物－Ｂ(02509) 股价在下午03:32比前收市价显著上升12.527%，现股价为港币$26.5。至目前为止，今日最高价为$26.5，而最低价为$23.0。总成交量为11.22万股，总成交金额为港币$278.589万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2406181017/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2444780172","title":"荃信生物直线拉升涨超11% 股价收复近半个月失地","url":"https://stock-news.laohu8.com/highlight/detail?id=2444780172","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444780172?lang=zh_cn&edition=full","pubTime":"2024-06-18 15:13","pubTimestamp":1718694833,"startTime":"0","endTime":"0","summary":"港股自身免疫第一股荃信生物-B午后直线拉升，一度大涨11.46%至26.25港元，股价收复近半个月失地，市值重回58亿港元上方。该试验为国内首个由中国企业开展的针对PN适应症的生物药临床试验，基于该项试验数据，QX005N于今年1月31日被国家药品监督管理局药品审评中心纳入突破性治疗品种名单。该行认为特应性皮炎生物制剂与银屑病药物需求增长将较快。","market":"sh","thumbnail":"http://imgcloud.jrjimg.cn/2024/06/cms_20240618151353696.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2024/06/cms_20240618151353696.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/06/18151341070323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2444387176","title":"港股异动 | 荃信生物-B(02509)午后涨超10% 治疗PN注射液研究结果显示主要终点达标","url":"https://stock-news.laohu8.com/highlight/detail?id=2444387176","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444387176?lang=zh_cn&edition=full","pubTime":"2024-06-18 14:04","pubTimestamp":1718690640,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B(02509)午后放量拉升逾10%，截至发稿，涨4.25%，报24.55港元，成交额213.89万港元。消息面上，荃信生物公布，QX005N注射液治疗结节性痒疹(PN)的II期临床试验数据在中华医学会第二十九次皮肤性病学术年会上以口头报告形式发布。基于试验数据，QX005N于今年1月31日被国家药品监督管理局药品审评中心纳入突破性治疗品种名单。据悉，该试验为国内首个由内地企业开展针对PN适应症的生物药临床试验，研究结果显示，本次临床试验各剂量组的主要终点完全达标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1136655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HSTECH","07226","YANG","02509","HSCEI"],"gpt_icon":0},{"id":"2443792482","title":"荃信生物(02509.HK)治疗PN注射液研究结果显示主要终点达标","url":"https://stock-news.laohu8.com/highlight/detail?id=2443792482","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443792482?lang=zh_cn&edition=full","pubTime":"2024-06-16 18:33","pubTimestamp":1718533980,"startTime":"0","endTime":"0","summary":"荃信生物－Ｂ(02509.HK) 公布，QX005N注射液治疗结节性痒疹“PN”II期临床试验数据在中华医学会第二十九次皮肤性病学术年会上以口头报告形式发布。基于试验数据，QX005N于今年1月31日被国家药品监督管理局药品审评中心纳入突破性治疗品种名单。该试验为国内首个由内地企业开展针对PN适应症的生物药临床试验，研究结果显示，本次临床试验各剂量组的主要终点完全达标。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1356712/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2443622786","title":"荃信生物-B：QX005N注射液治疗PN II期临床显著疗效，76.7%患者瘙痒改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2443622786","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443622786?lang=zh_cn&edition=full","pubTime":"2024-06-14 20:38","pubTimestamp":1718368711,"startTime":"0","endTime":"0","summary":"快讯正文荃信生物-B近日宣布，其QX005N注射液在治疗结节性痒疹的II期临床试验中取得积极成果。研究结果表明，QX005N注射液在各剂量组中均显示出显著的疗效。在第16周，300mg、450mg及600mg组的WI-NRS评分改善率分别为76.7%、83.3%及76.7%，远高于安慰剂组的30.0%。在改善皮损方面，各剂量组的表现也优于安慰剂组，显示出QX005N在治疗PN方面的潜力。安全性评估显示，QX005N注射液的耐受性良好，未观察到严重的药物相关不良事件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406142040429f3d1643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406142040429f3d1643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2443625430","title":"荃信生物-B(02509.HK)：QX005N注射液治疗结节性痒疹(PN)的II期临床试验数据于中华","url":"https://stock-news.laohu8.com/highlight/detail?id=2443625430","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443625430?lang=zh_cn&edition=full","pubTime":"2024-06-14 19:21","pubTimestamp":1718364115,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 荃信生物-B (02509.HK)公布，QX005N注射液治疗结节性痒疹(PN)的II期临床试验(CTR20223174)数据在中华医学会第二十九次皮肤性病学术年会上以口头报告形式发布。该试验为国内首个由中国企业开展的针对PN适应症的生物药临床试验，基于该项试验数据，QX005N于今年1月31日被国家药品监督管理局药品审评中心纳入突破性治疗品种名单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406141930499f3ce749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406141930499f3ce749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","BK1161","03347","02509","BK1576"],"gpt_icon":0},{"id":"2443611640","title":"荃信生物-B(02509)：QX005N注射液治疗结节性痒疹(PN)的II期临床试验数据于中华医学会第二十九次皮肤性病学术年会发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2443611640","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443611640?lang=zh_cn&edition=full","pubTime":"2024-06-14 18:33","pubTimestamp":1718361184,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 公布，QX005N注射液治疗结节性痒疹的II期临床试验数据在中华医学会第二十九次皮肤性病学术年会上以口头报告形式发布。该试验为国内首个由中国企业开展的针对PN适应症的生物药临床试验，基于该项试验数据，QX005N于今年1月31日被国家药品监督管理局药品审评中心纳入突破性治疗品种名单。此外，QX005N于给药首周即快速起效，并在第16周给药结束后，瘙痒改善疗效维持至第24周随访结束。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1135566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK1161","03347","BK1583","02509","BK1141"],"gpt_icon":0},{"id":"2442743243","title":"荃信生物－Ｂ(02509)股价下跌5.063%，现价港币$22.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2442743243","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442743243?lang=zh_cn&edition=full","pubTime":"2024-06-12 10:25","pubTimestamp":1718159100,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在上午10:25比前收市价下跌5.063%，现股价为港币$22.5。至目前为止，今日最高价为$23.9，而最低价为$22.5。总成交量为2.5万股，总成交金额为港币$57.755万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406121840/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2439662486","title":"港股异动 | 荃信生物-B(02509)涨超7% QX005N结节性痒疹Ⅲ期临床试验顺利达成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2439662486","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439662486?lang=zh_cn&edition=full","pubTime":"2024-05-30 14:21","pubTimestamp":1717050065,"startTime":"0","endTime":"0","summary":"消息面上，荃信生物宣布，公司自主研发的QX005N注射液达成结节性痒疹Ⅲ期临床试验首例受试者入组，这是国内首个由中国企业开展的针对PN适应症的III期临床试验。据悉，该试验是一项评价QX005N在治疗结节性痒疹成人受试者中的有效性和安全性的多中心、随机、双盲、安慰剂对照的III期临床研究，其主要研究目的是评估QX005N在PN受试者中对瘙痒缓解的有效性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1128225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","03347","BK1583","BK1576","YANG","BK1161","07226","BK1141","HSTECH","HSCEI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.2898},{"period":"3month","weight":-0.159},{"period":"6month","weight":0.0152},{"period":"ytd","weight":0.0152}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}